Featured Research

from universities, journals, and other organizations

important step in the activation of T-cells in the immune system explained

Date:
February 7, 2013
Source:
Albert-Ludwigs-Universität Freiburg
Summary:
Scientists have explained an important step in the activation of the so-called T-cells in the immune system. In humans and mice, T-cells are responsible for deciding whether a defense reaction should be activated to combat foreign substances.

The proline-rich region is hidden inside of the receptor of the T cell (left), and after a binding of an antigen the lower area of the receptor opens, exposing the region (right).
Credit: Wolfgang Schamel

A team headed by Prof. Dr. Wolfgang Schamel from the Institute of Biology III of the University of Freiburg and Prof. Dr. Balbino Alarcón from the Center for Molecular Biology Severo Ochoa of the Autonomous University of Madrid, Spain, has succeeded in explaining an important step in the activation of the so-called T-cells in the immune system. In humans and mice, T-cells are responsible for deciding whether a defense reaction should be activated to combat foreign substances.

Scientists want to prevent the receptor of the T-cells (TCR) from mistakenly also identifying the body's own tissue as a foreign substance to be fended off, because this can lead to autoimmune diseases such as multiple sclerosis. In order to do so, it is first necessary to elucidate the individual steps of TCR activation. Alarcón and Schamel published their findings on the exposure of the proline-rich region, an amino acid sequence in the TCR, in the current issue of the Journal of Immunology

As soon as foreign substances like bacteria or viruses engage with the TCR, this binding triggers the process of phosphorylation of the receptor, activating the immune defense. Scientists were previously unable to explain how the information that binding has taken place is transmitted into the inside of the TCR. Some time ago, Alarcón and Schamel already established that the receptor undergoes a change in structure as soon as a foreign substance from the outside binds: The proline-rich region is hidden inside of the TCR, and after a binding the lower area of the receptor opens, exposing the region. By studying the proline-rich region, the scientists have now succeeded in demonstrating that this exposure is important for phosphorylation.

The team led by Alarcón changed the receptors in mice by removing the proline-rich region. Dr. Aldo Borroto in Madrid and Dr. Elaine P. Dopfer in Freiburg determined that the TCR no longer functions correctly without this region, as it is no longer phosphorylated. In a receptor that has not been changed, however, the proline-rich region binds to the adapter protein Nck after the region has been exposed. Dopfer performed an in vitro reconstruction of this interaction, thus providing quantitative evidence for the study. This was done within the EU consortium SYBILLA "Systems biology on T-cell activation," where Schamel and Alarcón are partners.

Through their joint research, the scientists in Freiburg and Madrid verified that the presence and exposure of the proline-rich region is of fundamental significance for activating the TCR, and consequently the immune defense.. This finding will enable scientists to reach a more complete understanding of the process, from the binding of a foreign substance to the response from the immune system. It will now be possible to elucidate the subsequent steps, which have not yet been analyzed.

Schamel is a member of the Freiburg Cluster of Excellence BIOSS Centre for Biological Signalling Studies, the Spemann Graduate School of Biology and Medicine, and the Center for Chronic Immune Deficiency at the Freiburg University Medical Center. He also serves as coordinator of the EU FP7 network SYBILLA.


Story Source:

The above story is based on materials provided by Albert-Ludwigs-Universität Freiburg. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. Deswal, A. Meyer, G. J. Fiala, A. E. Eisenhardt, L. C. Schmitt, M. Salek, T. Brummer, O. Acuto, W. W. A. Schamel. Kidins220/ARMS Associates with B-Raf and the TCR, Promoting Sustained Erk Signaling in T Cells. The Journal of Immunology, 2013; DOI: 10.4049/jimmunol.1200653

Cite This Page:

Albert-Ludwigs-Universität Freiburg. "important step in the activation of T-cells in the immune system explained." ScienceDaily. ScienceDaily, 7 February 2013. <www.sciencedaily.com/releases/2013/02/130207074144.htm>.
Albert-Ludwigs-Universität Freiburg. (2013, February 7). important step in the activation of T-cells in the immune system explained. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2013/02/130207074144.htm
Albert-Ludwigs-Universität Freiburg. "important step in the activation of T-cells in the immune system explained." ScienceDaily. www.sciencedaily.com/releases/2013/02/130207074144.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins